• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications.

作者信息

Varelas Christos, Vlachaki Efthymia, Klonizakis Philippos, Pantelidou Despoina, Minti Fani, Diamantidis Michael, Sabanis Nikolaos, Koravou Evdoxia, Christodoulou Ioanna, Papadopoulou Despina, Theodoridou Stamatia, Touloumenidou Tasoula, Papalexandri Apostolia, Sakellari Ioanna, Vakalopoulou Sofia, Perifanis Vasilis, Vassilopoulos George, Mitroulis Ioannis, Gavriilaki Eleni

机构信息

Hematology Department General Hospital "George Papanikolaou" Thessaloniki Greece.

Adult Thalassaemia Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki Hippokration General Hospital of Thessaloniki Thessaloniki Greece.

出版信息

Hemasphere. 2024 Jul 25;8(7):e135. doi: 10.1002/hem3.135. eCollection 2024 Jul.

DOI:10.1002/hem3.135
PMID:39055645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270009/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/11270009/8cfd6a00541d/HEM3-8-e135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/11270009/26bb92349fe7/HEM3-8-e135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/11270009/8cfd6a00541d/HEM3-8-e135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/11270009/26bb92349fe7/HEM3-8-e135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80df/11270009/8cfd6a00541d/HEM3-8-e135-g001.jpg

相似文献

1
Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications.镰状细胞病及其并发症中补体激活和血栓炎症的前瞻性研究。
Hemasphere. 2024 Jul 25;8(7):e135. doi: 10.1002/hem3.135. eCollection 2024 Jul.
2
Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.补体成分 C5 和 TLR 分子 CD14 介导人血中血红素诱导的血栓炎症。
J Immunol. 2019 Sep 15;203(6):1571-1578. doi: 10.4049/jimmunol.1900047. Epub 2019 Aug 14.
3
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease.新兴的功能性微流控分析方法在镰状细胞病中血栓炎症研究中的应用。
Curr Opin Hematol. 2022 Nov 1;29(6):327-334. doi: 10.1097/MOH.0000000000000731. Epub 2022 Jul 18.
4
Venous Air Embolism Activates Complement C3 Without Corresponding C5 Activation and Trigger Thromboinflammation in Pigs.静脉空气栓塞会激活补体 C3，而不会相应地激活 C5，并在猪体内引发血栓炎症。
Front Immunol. 2022 Mar 15;13:839632. doi: 10.3389/fimmu.2022.839632. eCollection 2022.
5
Scorch processing of rhubarb (Rheum tanguticum Maxim. ex Balf.) pyrolyzed anthraquinone glucosides into aglycones and improved the therapeutic effects on thromboinflammation via regulating the complement and coagulation cascades pathway.大黄（唐古特大黄）焦炒处理可将其热解的蒽醌糖苷转化为苷元，并通过调节补体和凝血级联途径改善对血栓炎症的治疗效果。
J Ethnopharmacol. 2024 Oct 28;333:118475. doi: 10.1016/j.jep.2024.118475. Epub 2024 Jun 20.
6
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology.隐藏在血栓炎症背后的：揭示血管性血友病因子在镰状细胞病病理生理学中的作用。
Curr Opin Hematol. 2023 May 1;30(3):86-92. doi: 10.1097/MOH.0000000000000755. Epub 2023 Jan 12.
7
Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial.异槲皮素治疗镰状细胞病中的血栓炎症：一项随机、双盲、安慰剂对照试验。
Blood Adv. 2024 Jan 9;8(1):172-182. doi: 10.1182/bloodadvances.2023011542.
8
Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.血栓炎症支持 COVID-19 癌症患者的补体激活。
Front Immunol. 2021 Aug 18;12:716361. doi: 10.3389/fimmu.2021.716361. eCollection 2021.
9
Regulating Neutrophil PAD4/NOX-Dependent Cerebrovasular Thromboinflammation.调控中性粒细胞 PAD4/NOX 依赖性脑血管血栓炎症。
Int J Biol Sci. 2023 Jan 9;19(3):852-864. doi: 10.7150/ijbs.77434. eCollection 2023.
10
Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19.免疫血栓形成和补体激活导致 COVID-19 疾病严重程度和不良结局。
J Innate Immun. 2023;15(1):850-864. doi: 10.1159/000533339. Epub 2023 Nov 8.

引用本文的文献

1
Common Genetic Variants in Rare Disorders: Hematology and Beyond.罕见病中的常见基因变异：血液学及其他领域
Curr Issues Mol Biol. 2025 Jan 1;47(1):23. doi: 10.3390/cimb47010023.

本文引用的文献

1
MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.MASP-2 和 MASP-3 抑制剂可阻断镰状细胞病血管阻塞小鼠模型中的补体激活、炎症和微血管淤滞。
Transl Res. 2022 Nov;249:1-12. doi: 10.1016/j.trsl.2022.06.018. Epub 2022 Jul 22.
2
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.推进血液病治疗性补体抑制：PNH 及其他。
Blood. 2022 Jun 23;139(25):3571-3582. doi: 10.1182/blood.2021012860.
3
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
镰状细胞病稳态及急性血管闭塞性危机中ADAMTS13和血管性血友病因子评估
Res Pract Thromb Haemost. 2020 Dec 18;5(1):197-203. doi: 10.1002/rth2.12460. eCollection 2021 Jan.
4
Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing.镰状细胞病与靶向治疗中的补体：我只知道一件事，那就是我一无所知。
Blood Rev. 2021 Jul;48:100805. doi: 10.1016/j.blre.2021.100805. Epub 2021 Jan 21.
5
ADAMTS-13-VWF axis in sickle cell disease patients.ADAMTS-13-VWF 轴在镰状细胞病患者中的作用。
Ann Hematol. 2021 Feb;100(2):375-382. doi: 10.1007/s00277-020-04385-9. Epub 2021 Jan 6.
6
Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.移植前遗传易感性：移植相关性血栓性微血管病中的临床相关性。
Thromb Haemost. 2020 Apr;120(4):638-646. doi: 10.1055/s-0040-1702225. Epub 2020 Mar 4.
7
The multifaceted role of ischemia/reperfusion in sickle cell anemia.缺血/再灌注在镰状细胞贫血中的多效性作用。
J Clin Invest. 2020 Mar 2;130(3):1062-1072. doi: 10.1172/JCI133639.
8
Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.补体成分 C5 和 TLR 分子 CD14 介导人血中血红素诱导的血栓炎症。
J Immunol. 2019 Sep 15;203(6):1571-1578. doi: 10.4049/jimmunol.1900047. Epub 2019 Aug 14.
9
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.补体在血栓性微血管病中的作用：揭开补体治疗学迷宫中的阿里阿德涅之线。
Front Immunol. 2019 Feb 27;10:337. doi: 10.3389/fimmu.2019.00337. eCollection 2019.
10
Germline mutations in the alternative pathway of complement predispose to HELLP syndrome.胚系补体旁路基因突变可导致 HELLP 综合征。
JCI Insight. 2018 Mar 22;3(6):99128. doi: 10.1172/jci.insight.99128.